We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-1.25%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.8B
AUM Growth
-$213M
Cap. Flow
-$127M
Cap. Flow %
-4.53%
Top 10 Hldgs %
19.09%
Holding
295
New
22
Increased
61
Reduced
165
Closed
27

Top Sells

Rank Stock Value
1
SFLY
Shutterfly, Inc.
SFLY
+$46.3M
2
TFX icon
Teleflex
TFX
+$25.8M
3
ICUI icon
ICU Medical
ICUI
+$18.2M
4
CY
Cypress Semiconductor
CY
+$16.3M
5
BOX icon
Box
BOX
+$15.8M

Sector Composition

Rank Sector Weight
1 Industrials 23.77%
2 Healthcare 20.79%
3 Technology 17.8%
4 Consumer Discretionary 11.78%
5 Communication Services 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTN
101
DELISTED
OptiNose
OPTN
$9.67M 0.35%
92,059
-505
-0.5% -$50.4K
CAMP
102
DELISTED
CalAmp Corp.
CAMP
$9.52M 0.34%
35,939
-630
-2% -$155K
PRMW
103
DELISTED
Primo Water Corporation
PRMW
$9.46M 0.34%
758,355
+137,392
+22% +$1.75M
AAP icon
104
Advance Auto Parts
AAP
$3.49B
$9.09M 0.33%
54,967
-572
-1% -$86K
PGNX
105
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$8.98M 0.32%
1,776,490
-466,013
-21% -$2.32M
PCOM
106
DELISTED
Points.com Inc. Common Shares
PCOM
$8.64M 0.31%
787,919
+15,675
+2% +$182K
RETA
107
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$8.59M 0.31%
106,968
-2,163
-2% -$184K
INSM icon
108
Insmed
INSM
$28.6B
$8.16M 0.29%
462,527
-5,014
-1% -$96.8K
CSGP icon
109
CoStar Group
CSGP
$12.3B
$7.82M 0.28%
131,890
-32,020
-20% -$1.92M
OPLN
110
Openlane
OPLN
$4.54B
$7.65M 0.27%
311,514
-4,158
-1% -$106K
UTMD icon
111
Utah Medical Products
UTMD
$225M
$7.54M 0.27%
78,619
+566
+0.7% +$52.6K
YETI icon
112
Yeti Holdings
YETI
$3.95B
$7.32M 0.26%
+261,286
New +$7.92M
MIXT
113
DELISTED
MIX TELEMATICS LIMITED
MIXT
$6.93M 0.25%
496,629
-8,618
-2% -$126K
PBYI icon
114
Puma Biotechnology
PBYI
$454M
$5.96M 0.21%
553,992
-4,897
-0.9% -$52.9K
AKBA icon
115
Akebia Therapeutics
AKBA
$252M
$5.82M 0.21%
1,484,137
-9,933
-0.7% -$42.6K
NBIX icon
116
Neurocrine Biosciences
NBIX
$16.6B
$5.54M 0.2%
61,495
-654
-1% -$61.1K
ITRN icon
117
Ituran Location and Control
ITRN
$1.05B
$5.53M 0.2%
223,040
-1,668
-0.7% -$47.3K
BJRI icon
118
BJ's Restaurants
BJRI
$1.48B
$4.99M 0.18%
128,392
-3,613
-3% -$139K
IFF icon
119
International Flavors & Fragrances
IFF
$21.9B
$4.85M 0.17%
39,535
-422
-1% -$53.8K
JAZZ icon
120
Jazz Pharmaceuticals
JAZZ
$16.7B
$4.49M 0.16%
35,040
-800
-2% -$107K
GRUB
121
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$4.44M 0.16%
39,515
-414
-1% -$55K
BMRN icon
122
BioMarin Pharmaceuticals
BMRN
$12.4B
$4.43M 0.16%
65,666
-685
-1% -$52.8K
EW icon
123
Edwards Lifesciences
EW
$51.7B
$4.16M 0.15%
56,739
-4,038
-7% -$284K
VMC icon
124
Vulcan Materials
VMC
$36.9B
$3.95M 0.14%
26,088
-121
-0.5% -$17.1K
CSW
125
CSW Industrials
CSW
$5.71B
$3.68M 0.13%
53,266
+1,381
+3% +$95.4K

Similar funds

Rice Hall James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Rice Hall James & Associates held 295 positions worth $2.8B, down 7.1% from $3.01B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Rice Hall James & Associates withdrew a net $127M in Q3 2019, closing 27 positions and reducing 165 holdings. Its most notable exit was Shutterfly, Inc., an estimated $46.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Rice Hall James & Associates opened a new position in World Wrestling Entertainment worth $19.3M.

  • Rice Hall James & Associates's largest Q3 2019 buy was World Wrestling Entertainment: 271,808 shares worth $19.3M.
  • Rice Hall James & Associates added most to Medifast in Q3 2019, an estimated $21M increase.
  • Rice Hall James & Associates's biggest Q3 2019 reduction was Teleflex, cutting an estimated $25.8M.
  • Rice Hall James & Associates fully exited Shutterfly, Inc. in Q3 2019, selling an estimated $46.3M.
  • Rice Hall James & Associates's ten largest holdings make up 19% of its $2.8B portfolio in Q3 2019.
  • Rice Hall James & Associates opened 22 new positions and closed 27 in Q3 2019.
  • Rice Hall James & Associates's portfolio value fell 7.1% quarter-over-quarter to $2.8B.

Based on Rice Hall James & Associates's 13F filing for Q3 2019, filed 30 Oct 2019.